ProCE Banner Activity

Antimicrobial Resistance in Clostridioides difficile Infection

Clinical Thought

Here’s why I think we should pay more attention to the development of resistance to our agents for CDI treatment.

Released: May 18, 2023

Share

Faculty

Kevin Garey

Kevin Garey, PharmD, MS

Professor and Chair
Department of Pharmacy Practice and Translational Research
University of Houston College of Pharmacy
Houston, Texas

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Merck Sharp & Dohme Corp.

Merck Sharp & Dohme Corp.

Partners

Peggy Lillis Foundation

ProCE Banner

Disclosure

Primary Author

Kevin Garey, PharmD, MS

Professor and Chair
Department of Pharmacy Practice and Translational Research
University of Houston College of Pharmacy
Houston, Texas

Kevin Garey, PharmD, MS: researcher: Acurx Pharmaceuticals, Paratek Pharmaceuticals, Seres Health, Summit Pharmaceuticals.